ticagrelor [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

Significant heterogeneity in [[dual antiplatelet therapy]] regimens following [[Pipeline Embolization Device]] (PED) placement and associated costs, exists at major academic [[neurovascular center]]s. The most commonly used first line dual antiplatelet regimen consists of [[aspirin]] and [[clopidogrel]]. Two major alternate protocols involving [[ticagrelor]] and [[prasugrel]], are administered to clopidogrel hypo-responders. The optimal dual antiplatelet regimen for patients with cerebrovascular conditions has not been established, given limited prospective data within the neurointerventional literature
((Gupta R, Moore JM, Griessenauer CJ, Adeeb N, Patel AS, Youn R, Poliskey K,
Thomas AJ, Ogilvy CS. Assessment of Dual Antiplatelet Regimen for Pipeline
Embolization Device Placement: A Survey of Major Academic Neurovascular Centers
in the United States. World Neurosurg. 2016 Sep 15. pii: S1878-8750(16)30839-7.
doi: 10.1016/j.wneu.2016.09.013. [Epub ahead of print] PubMed PMID: 27641263.
)).